Cancer Family
Malignant Respiratory System Neoplasm
CI-CAN-00000249Explore in graph →
2,650 active trials51 approved drugs619 evidence items
- NCIt
- C4571
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000249Explore in graph →
Clinical trials
11,128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,492)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00891579 | Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations | completed | Phase 2 | 161 | Chinese Society of Lung CancerOTHER | 1 | Dec 10, 2012 | clinicaltrials |
| NCT00132665 | Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301) | completed | Phase 3 | 200 | Japan Clinical Oncology GroupOTHER |
| 1 |
| Dec 7, 2012 |
| clinicaltrials |
| NCT00173888 | Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | National Taiwan University HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00482014 | A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer | completed | Phase 1 / Phase 2 | 120 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 27, 2012 | clinicaltrials |
| NCT00984243 | Photodynamic Therapy (PDT) in Lung Cancer(PDT) | completed | N/A | 35 | Mayo ClinicOTHER | 1 | Nov 15, 2012 | clinicaltrials |
| NCT00193453 | Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 69 | SCRI Development Innovations, LLCOTHER | 1 | Nov 13, 2012 | clinicaltrials |
| NCT00128622 | Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | 24 | H. Kim LyerlyOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01466647 | A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC) | completed | Phase 1 | 12 | Axelar ABINDUSTRY | 1 | Nov 12, 2012 | clinicaltrials |
| NCT00005041 | R115777 in Treating Patients With Relapsed Small Cell Lung Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT01382667 | Plasma Levels of Glucagon-like Peptide-2 and Dyspepsia in Patients With Extraintestinal Cancer During Chemotherapy | completed | — | 70 | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisOTHER | 1 | Nov 9, 2012 | clinicaltrials |
| NCT00085501 | S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 242 | SWOG Cancer Research NetworkNETWORK | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00695994 | The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients | completed | Phase 2 | 300 | National University Hospital, SingaporeOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT01079520 | Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC) | completed | N/A | 138 | Samsung Medical CenterOTHER | 1 | Nov 1, 2012 | clinicaltrials |
| NCT00682383 | Combined Modality Therapy With Growth Factor Support in Locally Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 26 | Mt. Sinai Medical Center, MiamiOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00840125 | Study of Erlotinib With Docetaxel in Selected Non Small Cell Lung Cancer Patients in First Line Treatment | completed | Phase 2 | 4 | Meir Medical CenterOTHER | 1 | Oct 30, 2012 | clinicaltrials |
| NCT00415675 | Respiratory Tumor and Normal Tissue Motion | completed | — | 86 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00346801 | CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 20 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 22, 2012 | clinicaltrials |
| NCT00702182 | Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer | completed | Phase 1 | 30 | National Cancer Centre, SingaporeOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01385111 | Combined Application of EBUS and EUS in Lung Cancer | completed | N/A | 162 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 18, 2012 | clinicaltrials |
| NCT00078845 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | completed | Phase 2 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 17, 2012 | clinicaltrials |
| NCT00095199 | Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer | completed | Phase 3 | 939 | Eli Lilly and CompanyINDUSTRY | 2 | Oct 15, 2012 | clinicaltrials |
| NCT00002642 | SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung Cancer | completed | Phase 2 | 116 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00003587 | S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | 204 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 8, 2012 | clinicaltrials |
| NCT00006487 | S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer | completed | Phase 1 | 30 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00433407 | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | completed | N/A | 12 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00608868 | SELINE: Second-Line Iressa Phase IV Study in NSCLC Patients(SELINE) | completed | Phase 4 | 156 | AstraZenecaINDUSTRY | 1 | Sep 28, 2012 | clinicaltrials |
| NCT00712647 | Carotene and Retinol Efficacy Trial(CARET) | completed | Phase 4 | 18,314 | Fred Hutchinson Cancer CenterOTHER | 0 | Sep 26, 2012 | clinicaltrials |
| NCT01017133 | Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer | completed | Phase 1 | 56 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 26, 2012 | clinicaltrials |
| NCT01213030 | Clinical Evaluation of the New Hypoxia Imaging Agent HX4 | completed | Phase 1 / Phase 2 | 12 | Siemens Molecular ImagingINDUSTRY | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00004151 | Acridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 15 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 6 | Sep 24, 2012 | clinicaltrials |
| NCT00005055 | Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 39 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00006082 | Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer | completed | Phase 2 | 38 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00016211 | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 287 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Sep 24, 2012 | clinicaltrials |
| NCT00003072 | Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer | completed | Phase 2 | 80 | University of California, San FranciscoOTHER | 1 | Sep 21, 2012 | clinicaltrials |
| NCT01687439 | Effect of Endostar Combined With Chemotherapy and Radiotherapy on Blood Vessels and Microenvironment of Tumor for Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 15 | Fudan UniversityOTHER | 1 | Sep 19, 2012 | clinicaltrials |
| NCT00544336 | Family Quality of Life Among Families With a Member Who is a Cancer Patient | completed | — | 366 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00991796 | CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 109 | Daiichi SankyoINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT01167972 | Observational Study on the Management of Patients With Non Small Cell Lung Cancer Adenocarcinoma(MUTACT) | completed | — | 2,000 | AstraZenecaINDUSTRY | 1 | Sep 10, 2012 | clinicaltrials |
| NCT00083161 | Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 8 | Gundersen Lutheran Health SystemOTHER | 1 | Sep 5, 2012 | clinicaltrials |
| NCT01067794 | Chemotherapy in Treating Patients With Lung Cancer(FRAME) | completed | — | 1,610 | Eli Lilly and CompanyINDUSTRY | 0 | Aug 24, 2012 | clinicaltrials |
| NCT00988936 | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-angiogenic Drug(K5-101) | completed | Phase 2 | 35 | Siemens Molecular ImagingINDUSTRY | 1 | Aug 22, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00005093 | Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 2 | Aug 10, 2012 | clinicaltrials |
| NCT01274468 | Tumor Markers in Lung Cancer | completed | — | 10 | University of OklahomaOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT01578018 | Tumor Markers in Lung Cancer: DCAMLK-1LK-1 | completed | N/A | 49 | University of OklahomaOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00085839 | Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2 | completed | Phase 2 | 103 | OSI PharmaceuticalsINDUSTRY | 1 | Aug 9, 2012 | clinicaltrials |
| NCT00294762 | Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC | completed | Phase 2 | 143 | OSI PharmaceuticalsINDUSTRY | 2 | Aug 9, 2012 | clinicaltrials |
| NCT00004199 | Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer | completed | Phase 3 | — | PfizerINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00222144 | Study of Gleevec and Taxotere in Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 23 | University of KansasOTHER | 1 | Aug 7, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Dec 10, 2012source: clinicaltrials